Efficacy of Third-Generation EGFR-TKIs Combined with Stereotactic Radiotherapy for Brain Metastases in Non-Small Cell Lung Cancer
International Journal of Radiation Oncology*Biology*Physics · 2026-09 · 126 (1) · e753
DOI: 10.1016/j.ijrobp.2026.06.2285 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-09. Verfasst von H. Sun und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Sun, H., Lu, J., Chen, D., Xu, K., Jiang, W., & Liang, J. (2026). Efficacy of Third-Generation EGFR-TKIs Combined with Stereotactic Radiotherapy for Brain Metastases in Non-Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics, 126(1), e753. https://doi.org/10.1016/j.ijrobp.2026.06.2285
Vancouver
Sun H, Lu J, Chen D, Xu K, Jiang W, Liang J. Efficacy of Third-Generation EGFR-TKIs Combined with Stereotactic Radiotherapy for Brain Metastases in Non-Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 2026;126(1):e753. doi:10.1016/j.ijrobp.2026.06.2285
BibTeX
@article{Sun2026,
author = {Sun, H. and Lu, J. and Chen, D. and Xu, K. and Jiang, W. and Liang, J.},
title = {Efficacy of Third-Generation EGFR-TKIs Combined with Stereotactic Radiotherapy for Brain Metastases in Non-Small Cell Lung Cancer},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2026},
volume = {126},
number = {1},
pages = {e753},
doi = {10.1016/j.ijrobp.2026.06.2285}
}
EUVIMED